%0 Journal Article
%T Splitting random forest (SRF) for determining compact sets of genes that distinguish between cancer subtypes
%A Xiaowei Guan
%A Mark R Chance
%A Jill S Barnholtz-Sloan
%J Journal of Clinical Bioinformatics
%D 2012
%I BioMed Central
%R 10.1186/2043-9113-2-13
%X The optimal SRF 50 run (SRF50) gene classifiers for glioblastoma (GB), breast (BC) and ovarian cancer (OC) subtypes had overall prediction rates comparable to those from published datasets upon validation (80.1%-91.7%). The SRF50 sets outperformed other methods by identifying compact gene sets needed for distinguishing between tested cancer subtypes (10¨C200 fold fewer genes than ANOVA or published gene sets). The SRF50 sets achieved superior and robust overall and subtype prediction accuracies when compared with single random forest (RF) and the Top 50 ANOVA results (80.1% vs 77.8% for GB; 84.0% vs 74.1% for BC; 89.8% vs 88.9% for OC in SRF50 vs single RF comparison; 80.1% vs 77.2% for GB; 84.0% vs 82.7% for BC; 89.8% vs 87.0% for OC in SRF50 vs Top 50 ANOVA comparison). There was significant overlap between SRF50 and published gene sets, showing that SRF identifies the relevant sub-sets of important gene lists. Through Ingenuity Pathway Analysis (IPA), the overlap in ¡°hub¡± genes between the SRF50 and published genes sets were RB1, ¦ÐK3R1, PDGFBB and ERK1/2 for GB; ESR1, MYC, NFkB and ERK1/2 for BC; and Akt, FN1, NFkB, PDGFBB and ERK1/2 for OC.The SRF approach is an effective driver of biomarker discovery research that reduces the number of genes needed for robust classification, dissects complex, high dimensional ¡°omic¡± data and provides novel insights into the cellular mechanisms that define cancer subtypes.
%K Tree based models
%K High dimensional data
%K Cancer subtypes
%U http://www.jclinbioinformatics.com/content/2/1/13/abstract